LINANTA D 2.5/10
LINANTA D 2.5/10 is an effective combination used in the management of type 2 diabetes mellitus. It contains Linagliptin 2.5 mg + Dapagliflozin 10 mg, which work through complementary mechanisms to control blood glucose levels. Linagliptin improves insulin secretion, while Dapagliflozin helps remove excess glucose through urine. This combination supports better glycemic control, helps reduce HbA1c levels, and is beneficial in improving overall metabolic health in diabetic patients.
Related products
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
SITAMATA 50- 1000
Compositins : Each Film Coated Bilayered Tablet Contains: Sitagliptin Phosphate Monohydrate IP Eq to Sitagliptin...
MUCINIL TAB
COMPOSITION : N acetyl cysteine 150 mg and taurine 500 mg
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
DUET ACT 4 FORTE
DUET ACT 4 FORTE Tablet is a combination medicine used for managing type 2 diabetes...
DAPAGLIDE 10
COMPOSITION : Dapagliflozin 10 mg
GLIDA 2
Composition : glimepiride 40 mg
